Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck KGaA
Merck KGaA
Merck KGaA’s $6 Billion Millipore Deal ’Worth Every Euro’
Bloomberg
Fri, 04/9/10 - 07:53 am
Merck KGaA
M&A
Millipore
Merck KGaA Reviews Erbitux Heart Risk at EU Request
Bloomberg
Thu, 03/25/10 - 10:41 am
Europe
Merck KGaA
Erbitux
Merck KGaA halts cancer vaccine trial
Yahoo/AP
Tue, 03/23/10 - 11:12 am
Merck KGaA
vaccines
cancer
Stimuvax
Merck KGaA Issues Year’s Biggest Euro Company Bond to Fund Millipore
Bloomberg
Wed, 03/17/10 - 10:21 am
Merck KGaA
Millipore
M&A
OSI, Millipore takeover bids stoke biotech stocks
Marketwatch
Mon, 03/1/10 - 11:00 am
OSI Pharmaceuticals
Millipore
Astellas
drug stocks
M&A
Merck KGaA
Merck KGaA to Buy Millipore for About $6 Billion
Bloomberg
Mon, 03/1/10 - 09:50 am
Merck KGaA
Millipore
Thermo Fisher
M&A
Broker comments lift pharma stocks
FT.com
Mon, 02/8/10 - 10:18 am
drug stocks
Teva Pharmaceuticals
GSK
Pfizer
Shire
UCB Pharmaceuticals
Merck KGaA
Earnings Growth Proves Drugmaker Made Right Moves
Yahoo/AP
Fri, 02/5/10 - 09:54 am
earnings
Merck KGaA
Mylan
Teva Pharmaceuticals
Sandoz
Novartis
Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Thu, 01/21/10 - 09:01 am
MS
multiple sclerosis
Novartis
Merck KGaA
Merck KGaA Sticks to Pharmaceuticals Strategy, Handelsblatt Says
Bloomberg
Mon, 12/14/09 - 07:37 am
Merck KGaA
Can Novartis Win Race to Launch First Oral Drug for MS?
BNET Pharma
Fri, 12/4/09 - 08:38 am
MS
multiple sclerosis
Novartis
Merck KGaA
Germany's Merck will expand R&D in China
Yahoo/AP
Mon, 11/23/09 - 09:01 am
R&D
Merck KGaA
China
Breast Cancer Vaccine Tests German Merck’s $1 Billion Strategy
Bloomberg
Wed, 11/4/09 - 08:42 am
Merck KGaA
vaccines
breast cancer
Stimuvax
King Pharmaceuticals licenses US sales rights for cyanide antidote from Germany-based Merck
Yahoo/AP
Tue, 10/27/09 - 01:37 pm
Merck KGaA
King
liscensing
Cyanokit
Sanofi, Merck Among Global Bidders for iNova, Review Reports
Bloomberg
Fri, 10/9/09 - 10:01 am
iNova
Australia
Merck KGaA
Sanofi
Teva rivals advance on oral MS drug: Merck KGaA and Novartis have completed Phase III trials of their drugs, and are filing for approval
Trading Markets
Thu, 10/1/09 - 06:30 pm
Teva Pharmaceuticals
Novartis
multiple sclerosis
Merck KGaA
Conflicting Erbitux Study Data Hurts Merck Shrs
WSJ Online
Wed, 09/23/09 - 10:10 am
Merck KGaA
Erbitux
Merck KGaA’s Erbitux Failed to Extend Lives in Study
Bloomberg
Wed, 09/23/09 - 08:42 am
Merck KGaA
Erbitux
Eli Lilly
colon cancer
Merck KGaA pulls ahead in hot oral MS drug race
Fierce Biotech
Fri, 09/11/09 - 09:22 am
Merck KGaA
multiple sclerosis
MS
Small Biopharma Ponderings
Seeking Alpha
Mon, 07/27/09 - 11:20 am
Merck KGaA
Dendreon
Antigenics
Hemispherx
Oncothyreon
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
next ›
last »